Journal Information
Original article
Remdesivir plus dexamethasone is associated to improve in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status
Remdesivir más dexametasona se asocian a una reducción de los eventos clínicos en los pacientes hospitalizados por COVID-19, independientemente de su estado de vacunación
Enrique Bernala,
, Eva García-Villalbab, Eduardo Ponsa, Maria Dolores Hernándeza, Carlos Báguenaa, Gabriel Puchea, Paula Cartera, Mónica Martineza, Antonia Alcaraza, Cristina Tomása, Angeles Muñoza, Maria Rosario Vicentec, Maria Luz Nuñezc, Natalia Sanchoe, Mari Carmen Villalbaa, Alfredo Canoa, Alfredo Minguelad
Corresponding author
a Infectious Disease Unit, Reina Sofia University Hospital and Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
b Internal Medicine Service, Los Arcos del Mar Menor Hospital and Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
c Microbiology Service, Reina Sofia University Hospital and Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
d Immunology Service, Virgen de la Arrrixaca University Clinical Hospital (HCUVA), Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
e Laboratory Medicine Department, Reina Sofia University Hospital and Biomedical Research Institute of Murcia (IMIB), Murcia, Spain